Abstract:Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation, engendering transcript diversity, and modifications in protein structure and functionality. Across varying tissues, developmental stages, or under specific conditions, AS gives rise to distinct splice isoforms. This implies that these isoforms possess unique temporal and spatial roles, thereby associating AS with standard biological activities and diseases. Among these, AS-related RNA-binding proteins (RBPs) play an instrumental role in regulating alternative splicing events. Under physiological conditions, the diversity of proteins mediated by AS influences the structure, function, interaction, and localization of proteins, thereby participating in the differentiation and development of an array of tissues and organs. Under pathological conditions, alterations in AS are linked with various diseases, particularly cancer. These changes can lead to modifications in gene splicing patterns, culminating in changes or loss of protein functionality. For instance, in cancer, abnormalities in AS and RBPs may result in aberrant expression of cancer-associated genes, thereby promoting the onset and progression of tumors. AS and RBPs are also associated with numerous neurodegenerative diseases and autoimmune diseases. Consequently, the study of AS across different tissues holds significant value. This review provides a detailed account of the recent advancements in the study of alternative splicing and AS-related RNA-binding proteins in tissue development and diseases, which aids in deepening the understanding of gene expression complexity and offers new insights and methodologies for precision medicine.

Aberrant and alternative splicing in skeletal system disease.

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Therapeutic potential of alternative splicing in cardiovascular diseases

Mechanism of Alternative Splicing and Its Regulation.

Alternative Splicing of Pre-mRNA Matters in Oral Diseases.

Therapeutic strategies for aberrant splicing in cancer and genetic disorders

Aberrant RNA Splicing As the Molecular Basis of Some Pathogenic Variants.

Alternative splicing and related RNA binding proteins in human health and disease

Genomics of alternative splicing: evolution, development and pathophysiology

Alternative Splicing in Myeloid Malignancies

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

Targeting Serine- and Arginine-Rich Splicing Factors to Rectify Aberrant Alternative Splicing.

The molecular complexity of COL2A1 splicing variants and their significance in phenotype severity

Development and Disease-Specific Regulation of RNA Splicing in Cardiovascular System

Normal and aberrant splicing of LMNA

Alternative splicing and retinal degeneration

Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidence

Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease

Aberrant Alternative Splicing in Breast Cancer